Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
NCT00230321Phase 2Completed
- Start
- Feb 2002
- Primary completion
- Nov 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in myelodysplastic syndrome (MDS). Started Feb 2002; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00230321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230321.